BioLife Solutions, Inc. (BLFS) Ownership

NASDAQ: BLFSTop holders, insider trades and short interest.

BLFS ownership summary

as of October 17, 2026
Institutions
105.5%
of shares outstanding
Insiders
2.61%
of shares outstanding
Shares outstanding
48.9M
Float
40.1M
shares available to trade
Short interest
10.82%
3.9M shares short
Days to cover
4.54
short interest down 1.1% vs prior month
  • Institutions 105.51%
  • Insiders 2.61%

BLFS top institutional holders

20 largest
BioLife Solutions, Inc. top institutional holders
#Holder% of sharesSharesValueChangeReported
1T. Rowe Price Investment Management,Inc.13.80%6.8M$260.7M+244,789 (+3.8%)June 30, 2026
2BlackRock Inc13.03%6.4M$246.2M+273,780 (+4.5%)June 30, 2026
3Casdin Capital, LLC9.51%4.7M$179.7M−1.3M (−21.9%)June 30, 2026
4Amvescap Plc.4.58%2.2M$86.5M−108,109 (−4.6%)June 30, 2026
5Vanguard Capital Management, LLC4.01%2.0M$75.8M+46,376 (+2.4%)June 30, 2026
6State Street Corp3.38%1.7M$63.9M+78,851 (+5.0%)June 30, 2026
7Geode Capital Management, LLC2.22%1.1M$42.0M+114,938 (+11.8%)June 30, 2026
8Massachusetts Financial Services Company2.21%1.1M$41.7M−117,987 (−9.9%)June 30, 2026
9Fred Alger Management, LLC2.20%1.1M$41.6M−2,358 (−0.2%)June 30, 2026
10Dimensional Fund Advisors, Inc.2.14%1.0M$40.4M+10,495 (+1.0%)June 30, 2026
11FMR Inc2.03%993K$38.3M−477,146 (−32.5%)June 30, 2026
12Bank of America Corp1.94%950K$36.7M+46,056 (+5.1%)June 30, 2026
13Vanguard Portfolio Management, LLC1.87%913K$35.3M+48,188 (+5.6%)June 30, 2026
14Royal Bank of Canada1.82%891K$34.4M+5,610 (+0.6%)June 30, 2026
15UBS Group AG1.70%832K$32.1M+566,165 (+212.9%)June 30, 2026
16Stephens Inv Mgmt Group LLC1.45%709K$27.4M+35,537 (+5.3%)June 30, 2026
17Millennium Management LLC1.28%626K$24.2M+625,658 (0.0%)June 30, 2026
18Royce & Associates, LP1.28%624K$24.1M+39,864 (+6.8%)June 30, 2026
19Geneva Capital Management1.19%582K$22.5M−157,662 (−21.3%)June 30, 2026
20Cramer Rosenthal McGlynn LLC1.18%576K$22.2M−57,020 (−9.0%)June 30, 2026

Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 13 holders added 2.1M shares and 7 cut 2.2M.

BLFS top mutual fund and ETF holders

20 largest
BioLife Solutions, Inc. top fund holders
#Holder% of sharesSharesValueChangeReported
1iShares Core S&P Small-Cap ETF5.23%2.6M$98.9M+648 (+0.0%)September 30, 2026
2Vanguard MStar Total Stk Mkt Idx Invest2.99%1.5M$56.4M—August 31, 2026
3iShares Russell 2000 ETF2.28%1.1M$43.0M−12,864 (−1.1%)September 30, 2026
4T. Rowe Price Small-Cap Stock2.24%1.1M$42.4M−1.4M (−55.4%)August 31, 2026
5Invesco Main Street Small Cap R61.60%784K$30.3M—August 31, 2026
6T. Rowe Price Instl Small-Cap Stock1.30%638K$24.7M−688,705 (−51.9%)August 31, 2026
7T. Rowe Price Small-Cap Value1.28%628K$24.3M−5,759 (−0.9%)August 31, 2026
8Fidelity Small Cap Growth1.19%583K$22.5M—July 31, 2026
9Arbitrage R1.14%560K$21.6M+560,140 (0.0%)August 31, 2026
10Fidelity Small Cap Index0.95%466K$18.0M+3,838 (+0.8%)July 31, 2026
11Invesco V.I. Main Street Small Cap I0.82%399K$15.4M−14,366 (−3.5%)August 31, 2026
12State Street SPDR Port S&P 600 Sm CpETF0.81%394K$15.2M—September 30, 2026
13Alger Small Cap Focus I0.79%386K$14.9M−636,388 (−62.2%)July 31, 2026
14iShares Russell 2000 Value ETF0.67%326K$12.6M+494 (+0.2%)September 30, 2026
15Vanguard Tax-Managed Small Cap Adm0.61%299K$11.5M—August 31, 2026
16Fidelity Small Cap Growth K60.60%292K$11.3M—July 31, 2026
17Vanguard Russell 2000 ETF0.50%245K$9.5M+5,536 (+2.3%)August 31, 2026
18Royce Micro-Cap Trust0.48%234K$9.0M+8,111 (+3.6%)June 30, 2026
19MoA Small Cap Growth Fund0.47%231K$8.9M−49,794 (−17.7%)September 30, 2026
20Schwab US Small-Cap ETF™0.46%227K$8.8M+153 (+0.1%)September 30, 2026

Funds report holdings monthly or quarterly; dates differ by fund.

BLFS insider transactions

latest 20
BioLife Solutions, Inc. insider transactions
DateNameTransactionPriceSharesValue
2026-03-09Karen A FosterSell$20.00500$10,000
2026-03-05Karen A FosterSell$20.1596,923$2.0M
2026-03-03Aby J MathewSell$20.74529$10,971
2026-03-03Karen A FosterSell$20.74418$8,669
2026-03-03Sarah AebersoldSell$20.74219$4,542
2026-03-03Sean WernerSell$20.74111$2,302
2026-03-03Todd BerardSell$20.74353$7,321
2026-03-03Troy WichtermanSell$20.74588$12,195
2026-01-06Sarah AebersoldSell$25.59241$6,167
2026-01-06Troy WichtermanSell$25.59990$25,334
2026-01-06Todd BerardSell$25.59344$8,803
2026-01-06Karen A FosterSell$25.59335$8,573
2026-01-06Aby J MathewSell$25.59405$10,364
2025-12-15Amy DurossSell$24.602,000$49,200
2025-12-15Sarah AebersoldSell$24.46713$17,440
2025-12-09Aby J MathewSell$25.13631$15,857
2025-12-09Karen A FosterSell$25.13519$13,042
2025-12-09Sarah AebersoldSell$25.13233$5,855
2025-12-09Todd BerardSell$25.13358$8,997
2025-12-09Troy WichtermanSell$25.131,033$25,959

Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.

BLFS shares outstanding

Shares outstanding

Year-end shares outstanding, adjusted for splits.

Who owns BLFS

Institutional investors own 105.5% of BioLife Solutions's shares and insiders 2.61%. The largest holder is T. Rowe Price Investment Management,Inc. with 13.80% of the shares (6.8M), as of June 30, 2026. Among the top 20 institutions, 13 added shares and 7 reduced their stake in the latest filings. Short interest is 10.82% of the float, or 4.54 days of average trading volume. The share count rose 302.8% since 2014.

Related: BLFS analyst forecast, BLFS key metrics. See the BLFS stock overview for the latest quote and news.

BLFS ownership FAQ

Who owns the most BioLife Solutions stock?

The largest shareholders of BioLife Solutions are T. Rowe Price Investment Management,Inc. (13.80%), BlackRock Inc (13.03%), Casdin Capital, LLC (9.51%), Amvescap Plc. (4.58%), Vanguard Capital Management, LLC (4.01%).

What percentage of BioLife Solutions is owned by institutions?

Institutions hold 105.5% of BioLife Solutions's shares outstanding; insiders hold 2.61%.

Which funds own BioLife Solutions?

The largest fund holders of BioLife Solutions are iShares Core S&P Small-Cap ETF (5.23%), Vanguard MStar Total Stk Mkt Idx Invest (2.99%), iShares Russell 2000 ETF (2.28%), T. Rowe Price Small-Cap Stock (2.24%), Invesco Main Street Small Cap R6 (1.60%).

What is BioLife Solutions's short interest?

3.9M shares of BioLife Solutions were sold short, 10.82% of the float; at the average daily volume it would take 4.54 days to cover.

Are insiders buying or selling BioLife Solutions?

Of the latest 20 reported insider transactions in BioLife Solutions (since December 9, 2025), 0 were purchases and 20 were sales.

How many shares of BioLife Solutions are outstanding?

BioLife Solutions has 48.9M shares outstanding, of which 40.1M are in the public float.

Medical Instruments & Supplies: ownership